| Mrs Celine Richard, MD PHD | |
|
51 N Dunlap St # G10, Memphis, TN 38105-4625 | |
| (901) 287-7337 | |
| Not Available |
| Full Name | Mrs Celine Richard |
|---|---|
| Gender | Female |
| Speciality | Otolaryngology - Pediatric Otolaryngology |
| Location | 51 N Dunlap St # G10, Memphis, Tennessee |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1750909404 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207YP0228X | Otolaryngology - Pediatric Otolaryngology | 65584 (Tennessee) | Secondary |
| 207YP0228X | Otolaryngology - Pediatric Otolaryngology | 57.248750 (Ohio) | Primary |
| Entity Name | Ut Lebonheur Pediatric Specialists, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093024101 PECOS PAC ID: 7719173939 Enrollment ID: O20101130000117 |
News Archive
Chronic lymphocytic leukemia (CLL) is among the most frequent leukemias affecting adults in Western countries. It usually occurs in older patients, does not cause any symptoms for a long time and is often only discovered by accident. Despite treatment, relapses frequently occur. The immunologists Dr. Kristina Heinig and Dr. Uta Höpken (Max Delbrück Center for Molecular Medicine, MDC, Berlin-Buch) and the hematologist Dr. Armin Rehm (MDC and Charité - Universitätsmedizin Berlin) have now discovered why this is so.
Leire Garcia Navarro, a researcher at the School of Pharmacy of the University of Navarra, has developed a new treatment which slows the growth of colon and liver cancers.
Men who have sex with men (MSMs) are among the most high-risk groups for acquiring and transmitting HIV infection. A new study published in the journal JAMA Internal Medicinesays that the rate of detection of new infections is more than doubled when self-testing is available. This could increase access to early treatment and thus interrupt the chain of transmission among MSMs.
A new study identifies a molecule that is a probable driving force in colorectal cancer and suggests that the molecule could be an important target for colorectal cancer treatment and a valuable biomarker of tumor progression.
SurModics, Inc., a leading provider of drug delivery and surface modification technologies to the healthcare industry, and NuPathe Inc., a neuroscience-focused specialty pharmaceutical company, announced today that the companies have entered into a license agreement for drug delivery technology.
› Verified 9 days ago
| Entity Name | St Jude Childrens Research Hospital Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1306335088 PECOS PAC ID: 7315133444 Enrollment ID: O20180821000139 |
News Archive
Chronic lymphocytic leukemia (CLL) is among the most frequent leukemias affecting adults in Western countries. It usually occurs in older patients, does not cause any symptoms for a long time and is often only discovered by accident. Despite treatment, relapses frequently occur. The immunologists Dr. Kristina Heinig and Dr. Uta Höpken (Max Delbrück Center for Molecular Medicine, MDC, Berlin-Buch) and the hematologist Dr. Armin Rehm (MDC and Charité - Universitätsmedizin Berlin) have now discovered why this is so.
Leire Garcia Navarro, a researcher at the School of Pharmacy of the University of Navarra, has developed a new treatment which slows the growth of colon and liver cancers.
Men who have sex with men (MSMs) are among the most high-risk groups for acquiring and transmitting HIV infection. A new study published in the journal JAMA Internal Medicinesays that the rate of detection of new infections is more than doubled when self-testing is available. This could increase access to early treatment and thus interrupt the chain of transmission among MSMs.
A new study identifies a molecule that is a probable driving force in colorectal cancer and suggests that the molecule could be an important target for colorectal cancer treatment and a valuable biomarker of tumor progression.
SurModics, Inc., a leading provider of drug delivery and surface modification technologies to the healthcare industry, and NuPathe Inc., a neuroscience-focused specialty pharmaceutical company, announced today that the companies have entered into a license agreement for drug delivery technology.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Celine Richard, MD PHD Pediatric Ent Department, Nationwide Children's Hospita, 700 Children's Dr., Columbus, OH 43205 Ph: (614) 737-5744 | Mrs Celine Richard, MD PHD 51 N Dunlap St # G10, Memphis, TN 38105-4625 Ph: (901) 287-7337 |
News Archive
Chronic lymphocytic leukemia (CLL) is among the most frequent leukemias affecting adults in Western countries. It usually occurs in older patients, does not cause any symptoms for a long time and is often only discovered by accident. Despite treatment, relapses frequently occur. The immunologists Dr. Kristina Heinig and Dr. Uta Höpken (Max Delbrück Center for Molecular Medicine, MDC, Berlin-Buch) and the hematologist Dr. Armin Rehm (MDC and Charité - Universitätsmedizin Berlin) have now discovered why this is so.
Leire Garcia Navarro, a researcher at the School of Pharmacy of the University of Navarra, has developed a new treatment which slows the growth of colon and liver cancers.
Men who have sex with men (MSMs) are among the most high-risk groups for acquiring and transmitting HIV infection. A new study published in the journal JAMA Internal Medicinesays that the rate of detection of new infections is more than doubled when self-testing is available. This could increase access to early treatment and thus interrupt the chain of transmission among MSMs.
A new study identifies a molecule that is a probable driving force in colorectal cancer and suggests that the molecule could be an important target for colorectal cancer treatment and a valuable biomarker of tumor progression.
SurModics, Inc., a leading provider of drug delivery and surface modification technologies to the healthcare industry, and NuPathe Inc., a neuroscience-focused specialty pharmaceutical company, announced today that the companies have entered into a license agreement for drug delivery technology.
› Verified 9 days ago
Samuel Henry Smith, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: Universuty Of Tennessee, 920 Madison Avenue Suite 447, Memphis, TN 38163 Phone: 901-448-5885 | |
Dr. Anthony Sheyn, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 51 N Dunlap St, Suite G10, Memphis, TN 38105 Phone: 901-287-7337 Fax: 901-266-6620 | |
Dr. Christopher James Hall, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 5625 Poplar Ave, Memphis, TN 38119 Phone: 901-761-1220 Fax: 901-763-4332 | |
Dr. Victoria Lynn Lim, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 5625 Poplar Ave, Memphis, TN 38119 Phone: 901-761-1220 Fax: 901-763-4332 | |
Anas Eid, Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1068 Cresthaven Rd Ste 250, Memphis, TN 38119 Phone: 858-337-0500 | |
Robert James Yawn, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1325 Eastmoreland Ave Ste 260, Memphis, TN 38104 Phone: 901-272-6051 Fax: 901-266-6443 | |
Dr. Phillip R Langsdon, MD Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 1910 Nonconnah Blvd, Suite 120, Memphis, TN 38132 Phone: 901-448-2300 Fax: 901-448-6657 |